Clinical Trials on Measles Infection

Total 60928 results

Bandim Health Project

Unknown

Additional Measles Vaccine at 4 Months of Age

Measles Infection

Guinea-Bissau
Serum Institute of India Pvt. Ltd.
Centers for Disease Control and Prevention; University of Colorado, Boulder

Completed

A Clinical Trial to Assess the Safety of a Measles Vaccine (Dry Powder) Administered by Two Different Devices (PMV-001)

Prophylaxis for the Measles Infection

India
Bandim Health Project
Heidelberg University; Centre de Recherche en Sante de Nouna, Burkina Faso; Navrongo... and other collaborators

Unknown

Trial of Additional Measles Vaccine to Reduce Child Mortality. Burkina Faso.

Measles Vaccine

Burkina Faso
Postgraduate Institute of Medical Education and...

Unknown

Randomized Controlled Trial of Measles Vaccination Schedule

MEASLES DISEASE

India
Bandim Health Project
Heidelberg University; Centre de Recherche en Sante de Nouna, Burkina Faso; Navrongo... and other collaborators

Unknown

Trial of Additional Measles Vaccine to Reduce Child Mortality

Measles Vaccine

Guinea-Bissau
Takeda

Completed

Freeze-dried Live Attenuated Measles/Rubella Combined Vaccine (Schwarz FF-8 Strain/TO-336 Strain) Specified Drug-use Survey of Vaccinees After the Second Vaccination

Measles/Rubella

Japan
National Institute of Allergy and Infectious Diseases...
Johns Hopkins University

Recruiting

Investigation of Immune Amnesia Following Measles Infection in Select African Regions

Measles Infection

Guinea, Mali
Takeda

Completed

Freeze-dried Live Attenuated Measles/Rubella Combined Vaccine (Schwarz FF-8 Strain/TO-336 Strain) Special Drug Use Surveillance of Vaccinees After the First Vaccination

Measles/Rubella
Bandim Health Project

Enrolling by invitation

Measles Vaccination at Health System Contacts

Mortality | Measles Vaccine | Hospital Admission | Non-specific (Heterologous) Effects of Vaccines

Guinea-Bissau
GlaxoSmithKline

Completed

Safety and Immunogenicity Study of GlaxoSmithKline (GSK) Biologicals' Measles, Mumps and Rubella (MMR) Vaccine (209762) Compared to Merck & Co., Inc.'s MMR Vaccine in Healthy Children 12 to 15 Months of Age

Measles; Mumps; Rubella | Measles-Mumps-Rubella Vaccine

United States, Finland, Taiwan, Estonia, Puerto Rico
The Immunobiological Technology Institute (Bio-Manguinhos)...

Not yet recruiting

Immunity Duration Study Eight Years After Vaccination of Children 12 to 23 Months With the Triple Viral Vaccine (Measles, Mumps and Rubella)

Measles Vaccine
Johns Hopkins Bloomberg School of Public Health
London School of Hygiene and Tropical Medicine; Burroughs Wellcome; University...

Completed

Impact of HIV on Measles and Measles Immunisation

HIV Infection | Measles | Children

Zambia
Shanghai Institute Of Biological Products
Victoria Biomedical Research Institute

Not yet recruiting

Comparison Study of SIBP's MMR Vaccine Versus GSK MMR Vaccine in Children Aged 9-11 Months

Measles-Mumps-Rubella
GlaxoSmithKline

Active, not recruiting

A Study on the Immune Response and Safety of a Combined Measles, Mumps, Rubella, Chickenpox Vaccine Compared to a Marketed Combined Vaccine, Given to Healthy Children 4 to 6 Years of Age

Measles; Mumps; Rubella; Chickenpox

United States, Taiwan, Spain, Argentina, Turkey, Colombia, Puerto Rico, Latvia, Chile
Ignacio Zaragoza García
Hospital Universitario 12 de Octubre

Completed

Effectiveness of a Online Training Program With a Clinical Procedure Standardized in Units of Nursing (CPSUN) (CPSUN)

Infection Control | Preventive Measures

Spain
Bandim Health Project
Medical Research Council Unit, The Gambia

Completed

Prophylactic Antibiotics in Measles

Measles | Post-Measles Pneumonia

Guinea-Bissau
Bandim Health Project
Statens Serum Institut; Research Center for Vitamins and Vaccines

Unknown

Vaccine Campaign Effects on General Hospital Admissions and Mortality Among Children (RE-CAMP)

Mortality | Children | Oral Polio Vaccine | Morbidity | Measles Vaccination | Non-specific/Heterologous Effects of Vaccines

Guinea-Bissau
GlaxoSmithKline

Completed

Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Combined Measles-mumps-rubella (MMR) Vaccine in Children in Their Second Year of Life

Measles | Rubella | Mumps | Measles-Mumps-Rubella Vaccine

Finland, Thailand, United States, Spain, Czechia, Puerto Rico, Malaysia
GlaxoSmithKline

Completed

Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Combined Measles-mumps-rubella (MMR) Vaccine in Subjects Four to Six Years of Age

Measles-Mumps-Rubella

Taiwan, United States, Korea, Republic of
PATH

Completed

Coadministration of Measles-rubella and Rotavirus Vaccines

Measles Antibody Seroconversion | Rubella Antibody Seroconversion | Rotavirus Geometric Mean Titer (GMT) | Rotavirus Immunoglobulin A (IgA) Seropositivity

Bangladesh
GlaxoSmithKline

Completed

Immunogenicity of GSKs' MMR Vaccine (209762) vs. M-M-R® II, When Given With Routine Vaccines at 12-15 Months of Age

Measles | Rubella | Mumps | Measles-Mumps-Rubella Vaccine

United States, Puerto Rico
IDinsight
GiveWell

Completed

Measles Vaccination Cash Incentives Experimental Evidence From Nigeria

Measles

Nigeria
Bavarian Nordic

Completed

Study to Evaluate Safety, Dose Response and Immunogenicity of the Measles Vaccine MVA mBN85B in Healthy Children Aged 6 Months to 6 Years

Measles

South Africa
Bandim Health Project
Novo Nordisk A/S; Danish Council for Development Research; Fonden til Lægevidenskabens... and other collaborators

Completed

Long-term Follow-up of Measles Antibodies

Measles

Guinea-Bissau
The Immunobiological Technology Institute (Bio-Manguinhos)...

Completed

Secondary Attack Rate Measles Vaccine In Second Situation Contacts Cases Confirmed

Measles

Brazil
Dilla University

Not yet recruiting

Participant Centered Active Surveillance for Adverse Event Following Measles Immunization in Gedeo Zone, Ethiopia, 2022. A Multi-center Open-label Randomized Control Trial

Measles

Ethiopia
National Institute of Allergy and Infectious Diseases...

Completed

Phase I Trial of Measles Vectored Chikungungya Vaccine

Chikungunya Virus Infection

United States
Bandim Health Project
Institudo Nacional de Saude Publica INASA

Completed

The Effect on Overall Mortality of a National Policy of Limiting Measles Vaccination to Children Below 12 Months of Age (MVEPI)

Mortality | Vaccines

Guinea-Bissau
Kanuni Sultan Suleyman Training and Research Hospital

Completed

Do Childhood Measles and DTaP Vaccination Decrease the Mortality Rate Caused by COVID-19 in OECD Countries?

Covid19 | Mortality | Measles Vaccine

Turkey
Institut Pasteur de Dakar
Epicentre; Ministry of Health, Senegal

Not yet recruiting

Clinical Diagnostic Performance Evaluation of a Measles Rapid Test in Senegal

Measles
Marmara University

Completed

Evaluation of Pediatric Measles Cases in 2019: Single-Center Experience

Measles

Turkey
Stanford University

Completed

Ontogeny of Measles Immunity in Infants

Measles

United States
Johns Hopkins Bloomberg School of Public Health
Bill and Melinda Gates Foundation; Kenya Medical Research Institute

Completed

Mobile and Scalable Innovations for Measles Immunization: a Randomized Controlled Trial (M-SIMI)

Measles
Bandim Health Project

Unknown

mHealth to Increase Measles Immunization - a Randomized Controlled Trial in Guinea-Bissau (mimi)

Measles

Guinea-Bissau
Queen Saovabha Memorial Institute

Unknown

Immunity to Measles Virus in the Thai Population Age 18-30 Years and Predictive Factors

Measles

Thailand
Bandim Health Project
Danish Council for Development Research; Medical Research Council Unit, The... and other collaborators

Completed

Non-Specific Effects of Standard Titre Measles Vaccination

Measles

Guinea-Bissau
PT Bio Farma

Completed

Immunogenicity & Safety of Bio Farma's Measles-Rubella (MR) Vaccine in Indonesian Infants (Bridging Study)

Measles | Congenital Rubella Infection

Indonesia
Hospices Civils de Lyon

Recruiting

Monitoring of Measles-specific Immune Status in Adult Allogeneic Hematopoietic Stem Cell Transplant Recipients (MaRROwVacc)

Transplantation, Hematopoietic Stem Cell

France
Bandim Health Project

Completed

A Second Dose of Measles Vaccine (MV) in the Second Year of Life

Child Mortality | Child Morbidity

Guinea-Bissau
University of North Carolina, Chapel Hill
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

Immune Reconstitution to Measles Virus of HIV Infected Children in Zambia

Measles

Zambia
The Immunobiological Technology Institute (Bio-Manguinhos)...
Oswaldo Cruz Institute

Completed

Study to Evaluate the Immunogenicity, Reatogenicity and Safety of Double Viral Vaccine (MR) for Measles and Rubella (BIOMR)

Measles | Rubella

Brazil
Klara M. Pósfay Barbe
University Hospital, Geneva

Recruiting

Induction of Immunity Against Measles in Pediatric Liver Transplant Recipients (MMRinOLT)

Measles

Switzerland
Merck Sharp & Dohme LLC

Completed

A Measles, Mumps, and Rubella Investigational Vaccine Trial (V205C-010)(COMPLETED)

Measles
Merck Sharp & Dohme LLC

Completed

ProQuad® Intramuscular vs Subcutaneous

Measles | Rubella | Mumps | Varicella
Merck Sharp & Dohme LLC

Completed

Safety, Tolerability, and Immunogenicity of an Investigational Vaccine With Recombinant Human Albumin (rHA) in Children 12 to 18 Months of Age (V205C-009)(COMPLETED)

Measles | Rubella | Mumps | Varicella
PT Bio Farma

Completed

Reactogenicity and Protectivity Following Measles- Rubella (MR) Routine Immunization in Indonesian Infants and Children

Safety Issues | Immunogenicity

Indonesia
Micron Biomedical, Inc
Medical Research Council; Centers for Disease Control and Prevention

Completed

Measles and Rubella Vaccine Microneedle Patch Phase 1-2 Age De-escalation Trial

Healthy | Measles | Rubella | Vaccination

Gambia
The Immunobiological Technology Institute (Bio-Manguinhos)...
Bill and Melinda Gates Foundation

Completed

Study to Evaluate Safety and Imunogenicity of Double Viral Vaccine (MR) for Measles and Rubella (MR)

Measles | Rubella

Brazil
CHU de Quebec-Universite Laval
GlaxoSmithKline

Unknown

MMR and MMRV Vaccines: Effect of Age at First Dose on Safety and Immunogenicity of the Measles Component.

Measles
University of Toronto
International Care Ministries, the Philippines

Recruiting

A Tool Kit to Improve Vaccine Confidence in the Philippines

Measles | Polio | Vaccination Hesitancy

Philippines

Clinical Trials on Measles Infection

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Spain

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations